Sign In
Buy PDS
$95.01
+1.95 (+2.10%)
At Close: Jun 03, 2026
“The global drill bit market is expanding rapidly, driven by rising demand from industries like oil & gas, mining, aerospace, and construction for durable, high-performance drilling technologies.”
Precision Drilling: Capitalizing On Strong Activity In Canada
11:59pm, Sunday, 17'th Nov 2024
Precision Drilling's Q3 report shows strong performance in Canada, where rig demand is at multiyear highs. While the U.S. market remains a weakness, Precision Drilling is generating adequate margins o
EMV Capital highlights progress update from portfolio company PDS Biotech
11:03am, Thursday, 14'th Nov 2024
EMV Capital (AIM:EMVC) has noted the clinical progress update from portfolio company PDS Biotechnology alongside its third-quarter update. Frank Bedu-Addo, PDS chief executive, said: "Since our las
Patterson Dental Extends Strategic Relationship With PDS Health
07:00am, Wednesday, 13'th Nov 2024
ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Dental Supply, Inc., a subsidiary of Patterson Companies, Inc. (Nasdaq: PDCO), today announced an agreement in principle between Patterson and PDS Health, a
PDS Biotech to Announce Third Quarter Financial Results on November 14, 2024 at 8:30 a.m. Eastern Time
08:00am, Wednesday, 06'th Nov 2024
PRINCETON, N.J., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how
Precision Drilling Corporation (PDS) Q3 2024 Earnings Conference Call Transcript
05:16pm, Wednesday, 30'th Oct 2024
Precision Drilling Corporation (NYSE:PDS ) Q3 2024 Earnings Conference Call October 30, 2024 1:00 PM ET Company Participants Lavonne Zdunich - VP, IR Carey Ford - CFO Kevin Neveu - President and CEO C
Precision Drilling (PDS) Surpasses Q3 Earnings Estimates
07:41pm, Tuesday, 29'th Oct 2024
Precision Drilling (PDS) came out with quarterly earnings of $1.69 per share, beating the Zacks Consensus Estimate of $1.55 per share. This compares to earnings of $1.08 per share a year ago.
Precision Drilling Announces 2024 Third Quarter Unaudited Financial Results
05:25pm, Tuesday, 29'th Oct 2024
CALGARY, Alberta, Oct. 29, 2024 (GLOBE NEWSWIRE) -- This news release contains “forward-looking information and statements” within the meaning of applicable securities laws. For a full disclosure
Precision Drilling Corporation 2024 Third Quarter Results Conference Call and Webcast
04:00pm, Wednesday, 02'nd Oct 2024
CALGARY, Alberta, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Precision Drilling Corporation (Precision) intends to release its 2024 third quarter results after the market closes on Tuesday, October 29, 2024, a
100% 36-month overall survival (OS) and progression-free survival (PFS) rates in patients fully treated with Versamune ® HPV combined with chemoradiation (N=8) 88% (15/17) of patients had a complet
Precision Drilling: Get 20% Free Cash Flow Yield At The Cyclical Bottom
11:07pm, Monday, 23'rd Sep 2024
U.S. drilling activity is at a cyclical bottom, but Canada is at multiyear highs. The Canadian exposure and its high-spec rigs allow Precision Drilling to maintain a 20% FCF yield even now. Investors
PDS Biotechnology: Continuing The Holding Pattern
10:39am, Monday, 23'rd Sep 2024
PDS Biotechnology is focusing on an HPV-directed immunotherapy as its main near-term hope, with new data presented at the ESMO Congress. Strengths include promising clinical data and a focused pipelin
Precision Drilling Announces Renewal of Normal Course Issuer Bid
06:00am, Friday, 13'th Sep 2024
CALGARY, Alberta, Sept. 13, 2024 (GLOBE NEWSWIRE) -- This news release contains "forward-looking information and statements" within the meaning of applicable securities laws. For a full disclosure of
PDS Biotech to Present Updated VERSATILE-002 Data at ESMO Congress 2024
08:00am, Monday, 09'th Sep 2024
PRINCETON, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming ho
PDS Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference
08:00am, Tuesday, 03'rd Sep 2024
PRINCETON, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming ho
